Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and threonine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with threonine in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(threonine)
Trials
(threonine)
Recent Studies (post-2010) (threonine)
9,15618755210,383982,176

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Argenziano, M; Besana, A; Comas, GM; Danilo, P; Feinmark, SJ; Harleton, E; Robinson, RB; Rosen, MR; Rosen, TS1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and threonine

ArticleYear
Ability to induce atrial fibrillation in the peri-operative period is associated with phosphorylation-dependent inhibition of TWIK protein-related acid-sensitive potassium channel 1 (TASK-1).
    The Journal of biological chemistry, 2013, Jan-25, Volume: 288, Issue:4

    Topics: Animals; Atrial Fibrillation; CHO Cells; Cricetinae; Cricetulus; Dogs; Electrophysiology; Humans; Inflammation; Male; Muscle Cells; Nerve Tissue Proteins; Perioperative Period; Peroxidase; Phosphorylation; Platelet Activating Factor; Potassium Channels, Tandem Pore Domain; Protein Kinase C; Threonine

2013